Possible ways nucleoside analogues can affect mitochondrial DNA content and gene expression during HIV therapy.
about
The roles of HIV-1 proteins and antiretroviral drug therapy in HIV-1-associated endothelial dysfunctionImpact of Anti-Retroviral Treatment and Cotrimoxazole Prophylaxis on Helminth Infections in HIV-Infected Patients in Lambaréné, GabonAntiretroviral therapy-induced mitochondrial toxicity: potential mechanisms beyond polymerase-γ inhibition.Thymidine kinase 2 deficiency-induced mitochondrial DNA depletion causes abnormal development of adipose tissues and adipokine levels in miceZidovudine exposure in HIV-1 infected Tanzanian women increases mitochondrial DNA levels in placenta and umbilical cordsQuality assessment of human mitochondrial DNA quantification: MITONAUTS, an international multicentre survey.HIV and HAART-Associated DyslipidemiaPlasma cytokine profiles in HIV-1 infected patients developing neuropathic symptoms shortly after commencing antiretroviral therapy: a case-control study.Evidence of Subclinical mtDNA Alterations in HIV-Infected Pregnant Women Receiving Combination Antiretroviral Therapy Compared to HIV-Negative Pregnant Women.Absence of a universal mechanism of mitochondrial toxicity by nucleoside analogs.Thymidine analogues suppress autophagy and adipogenesis in cultured adipocytes.Intermuscular adipose tissue and metabolic associations in HIV infectionRole of mitochondria in HIV infection and associated metabolic disorders: focus on nonalcoholic fatty liver disease and lipodystrophy syndrome.Adipose Tissue in HIV Infection.Zidovudine impairs adipogenic differentiation through inhibition of clonal expansion.Beyond the polymerase-γ theory: Production of ROS as a mode of NRTI-induced mitochondrial toxicity.Adipose Tissue is Enriched for Activated and Late-Differentiated CD8+ T Cells and Shows Distinct CD8+ Receptor Usage, Compared With Blood in HIV-Infected Persons.NAFLD and HIV: Do Sex, Race, and Ethnicity Explain HIV-Related Risk?Examining Relationships between Metabolism and Persistent Inflammation in HIV Patients on Antiretroviral Therapy
P2860
Q28386344-FC2D21A0-25A2-44D2-83B0-AB82A89460C3Q28547359-4D87CBF7-F74C-4FBB-B648-F70D89F1413AQ33784656-2876FBAF-9853-4DFC-BEE4-5F571E535036Q34117877-893BD499-4257-4655-9A1F-711C2BFC4B6DQ34358732-D072DAD4-C2C6-4576-AE1B-EF1FEB1EF711Q34785931-51F32A24-9A5C-455D-B89A-3B03576892D5Q35020217-0379815A-9312-4C8A-8BD0-E3C24C81E31FQ35089902-FB89D1BB-9A95-4F2F-9E51-C0AFF22F9A8AQ35738557-24502844-C2D1-4FA5-9AAE-3ADB3F1AE7AEQ35879021-29965D50-8EF4-40DC-8202-780C59D07C52Q36505451-6DDD9480-5D2F-4F69-9677-9731DFC4B025Q37063431-3719CCA9-4133-4985-B828-86C817916F36Q37077573-04815DE1-DF97-4D35-BAA5-5CDC9F56C470Q40038736-8A91C50A-E578-4D2F-AAF3-A979A53970D5Q41338522-2CF37E1A-BB53-4ECB-AB64-30A99C746D70Q44797235-046EB026-E005-4DF3-AA94-EB991FFD3C06Q47609834-8933AA11-5332-49B0-BA49-3351EB55A102Q54232638-0721D96E-CBAE-48D0-AB6F-E7A9B44C4210Q58549748-85646474-44C2-49FE-9DF5-BA30069875CE
P2860
Possible ways nucleoside analogues can affect mitochondrial DNA content and gene expression during HIV therapy.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Possible ways nucleoside analo ...... expression during HIV therapy.
@ast
Possible ways nucleoside analo ...... expression during HIV therapy.
@en
type
label
Possible ways nucleoside analo ...... expression during HIV therapy.
@ast
Possible ways nucleoside analo ...... expression during HIV therapy.
@en
prefLabel
Possible ways nucleoside analo ...... expression during HIV therapy.
@ast
Possible ways nucleoside analo ...... expression during HIV therapy.
@en
P1433
P1476
Possible ways nucleoside analo ...... expression during HIV therapy.
@en
P2093
Hélène C F Côté
P478
10 Suppl 2
P577
2005-01-01T00:00:00Z